Article

Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification

University of Brighton, United Kingdom.
Experimental gerontology (Impact Factor: 3.49). 07/2009; 44(10):659-65. DOI: 10.1016/j.exger.2009.07.004
Source: PubMed

ABSTRACT

Little is known about the senescent phenotype of human vascular smooth muscle cells (VSMCs) and the potential involvement of senescent VSMCs in age-related vascular disease, such as atherosclerosis. As such, VSMCs were grown and characterised in vitro to generate senescent VSMCs needed for microarray analysis (Affymetrix). Comparative analysis of the transcriptome profiles of early (14 CPD) and late (39-42 CPD) passage VSMCs found a total of 327 probesets called as differentially expressed: 149 are up-regulated in senescence and 178 repressed (p-value<0.5%, minimum effect size of at least 2-fold differential regulation, explore data at http://www.madras.cf.ac.uk/vsmc). Data mining shows a differential regulation of genes at senescence associated with the development of atherosclerosis and vascular calcification. These included genes with roles in inflammation (IL1beta, IL8, ICAM1, TNFAP3, ESM1 and CCL2), tissue remodelling (VEGF, VEGFbeta, ADM and MMP14) and vascular calcification (MGP, BMP2, SPP1, OPG and DCN). The microarray data for IL1beta, IL8 and MGP were validated by either, ELISA, Western blot analysis or RT-PCR. These data thus provide the first evidence for a role of VSMC senescence in the development of vascular calcification and provides further support for the involvement of senescent VSMCs in the progression of atherosclerosis.

Download full-text

Full-text

Available from: Dominick G.A Burton
  • Source
    • "This process results, amongst other factors, from the activation of osteoblastic transcription factors, like Runx2, and from oxidative and inflammation pathways[27e29]. Calcification of VSMCs, associated with premature senescence[30], could lead to arterial calcification and stiffening[31]as observed in patients with HGPS and LMNA-linked progeroid syndromes[12,14]. Coronary artery calcium score, a marker of vascular age and subclinical atherosclerosis[32], is increased in HIV-infected patients[33,34], and long-term antiviral therapy including PIs is associated with vascular calcification[33,35,36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Some LMNA mutations responsible for lipodystrophies, and some HIV-protease inhibitors (PIs) induce accumulation of farnesylated prelamin A and premature senescence in some cell types. Patients with LMNA mutations or under PI-based therapy suffer from early atherosclerosis. The metalloprotease ZMPSTE24 is the key enzyme in prelamin A maturation. Aim: We studied whether altered expression of ZMPSTE24 could contribute to vascular cell dysfunction in response to LMNA mutations or PI treatments. Methods: Protein expression of prelamin A and ZMPSTE24 were evaluated in patients' cells and in human cultured VSMCs. Oxidative stress, inflammation, senescence and transdifferentiation/calcification were evaluated in VSMCs. Results: Fibroblasts from LMNA-mutated lipodystrophic patients (mutations R482W, D47Y or R133L) and peripheral blood mononuclear cells from PI-treated-HIV-infected patients expressed increased prelamin A and decreased ZMPSTE24, which was also observed in VSMCs overexpressing mutant LMNA or treated with PIs. These alterations correlated with oxidative stress, inflammation, senescence and calcification (all p < 0.05). ZMPSTE24 silencing in native VSMCs recapitulated the mutant LMNA- and PI-induced accumulation of farnesylated prelamin A, oxidative stress, inflammation, senescence and calcification. A negative regulator of ZMPSTE24, miRNA-141-3p, was enhanced in LMNA-mutated or PI-treated VSMCs. The farnesylation inhibitors pravastatin and FTI-277, or the antioxidant N-acetyl cysteine, partly restored ZMPSTE24 expression, and concomitantly decreased oxidative stress, inflammation, senescence, and calcification of PI-treated VSCMs. Conclusions: ZMPSTE24 downregulation is a major contributor in VSMC dysfunctions resulting from LMNA mutations or PI treatments that could translate in early atherosclerosis at the clinical level. These novel pathophysiological mechanisms could open new therapeutic perspectives for cardiovascular aging.
    Full-text · Article · Jan 2016 · Atherosclerosis
  • Source
    • "ismal lifespan entry into the senescent state probably prevents the growth of tumors , thus contributing to organismal survival . However , cellular senescence is typically associated with the heavily upregulated secretion of proinflammatory factors and other changes which have the potential to produce degenerative effects ( Coppé et al . , 2008 ; Burton et al . , 2009 ; Kipling et al . , 2009 ) . As a result of declining clearance rates with age senescent cells accumulate in multiple tissues with in vivo age in a variety of species ( Kipling et al . , 2004 ; Herbig et al . , 2006 ) . The best evidence that senescent cells play a causal role in aging is the recent observation that their ablation in a "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aging of the population represents one of the largest healthcare challenges facing the world today. The available scientific evidence shows that interventions are available now that can target fundamental "aging" processes or pathways. Sufficient economic evidence is available to argue convincingly that this approach will also save enormous sums of money which could then be deployed to solve other urgent global problems. However, as yet this scenario has barely entered the public consciousness and, far from being a point of vigorous debate, seems to be ignored by policy makers. Understanding why this lethargy exists is important given the urgent need to deal with the challenge represented by population aging. In this paper I hypothesize that one major cause of inaction is a widely held, but flawed, conceptual framework concerning the relationship between aging and disease that categorizes the former as "natural" and the latter as "abnormal." This perspective is sufficient in itself to act as a disincentive to intervention by rendering those who hold it prone to the "naturalistic fallacy" but can give rise to active hostility to biogerontology if coupled with loose and/or blurred understanding of the goals and potential of the field.
    Full-text · Article · Jul 2015 · Frontiers in Genetics
  • Source
    • "This process results, amongst other factors, from the activation of osteoblastic transcription factors, like Runx2, and from oxidative and inflammation pathways[27e29]. Calcification of VSMCs, associated with premature senescence[30], could lead to arterial calcification and stiffening[31]as observed in patients with HGPS and LMNA-linked progeroid syndromes[12,14]. Coronary artery calcium score, a marker of vascular age and subclinical atherosclerosis[32], is increased in HIV-infected patients[33,34], and long-term antiviral therapy including PIs is associated with vascular calcification[33,35,36]. "

    Full-text · Article · Jul 2015 · Atherosclerosis
Show more